
On July 29th, according to sources, a Form Four male student in Dengkil, Gan Ma Wan, Malaysia, is suspected to have consumed an e-liquid containing ingredients of "magic mushrooms," leading to loss of consciousness and seizures. The student is currently receiving treatment at a hospital in Gan Ma Wan.
According to reports, on July 22nd, the student who had fallen into a coma at school was transferred to the emergency room at Wànggānmǎwǎn Hospital for treatment. The hospital found that the student had experienced severe seizures due to ingesting an excessive amount of dangerous synthetic chemicals (synthetic cannabinoids).
The news also indicates that e-cigarettes had already infiltrated the school as early as 3 years ago, a situation that is concerning.
Currently, the student is still receiving medical treatment in the hospital, and the condition has not shown significant improvement. The family reported the incident to the police last Friday, July 27th, seeking assistance and investigation into the cause of the incident.
The Director of Ganma Wan Police District, Hanyan Ramlan, confirmed that the police have received reports from concerned parents and will launch a further investigation to ensure the safety and health of the students.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.